Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TK1 | P04183 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | TK2 | O00142 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16772812 | 0.88 | TYMS (0.36) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL20215608 | 0.87 | TYMS (0.35) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL16772883 | 0.86 | TYMS (0.34) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL8739275 | 0.81 | TYMS (0.35) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL12537242 | 0.80 | TYMS (0.33) | TYMS | |
| SCHEMBL25972011 | 0.79 | TYMS (0.49) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL25521863 | 0.79 | CYP1A2 (0.34) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL26144928 | 0.75 | TYMS (0.42) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL25521874 | 0.75 | CYP1A2 (0.30) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL13403288 | 0.74 | TYMS (0.30) | TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8354523-B2 | Oligonucleotide probes and uses thereof | ALLELOGIC BIOSCIENCES CORPORATION (US) | 2013-01-15 | — | — | US | disclosed |
| US-20100240103-A1 | OLIGONUCLEOTIDES LABELED WITH A PLURALITY OF FLUOROPHORES | ALLELOGIC BIOSCIENCES CORPORATION | 2010-09-23 | — | — | US | disclosed |
| US-20100086916-A1 | OLIGONUCLEOTIDE PROBES AND USES THEREOF | ALLELOGIC BIOSCIENCES CORPORATION | 2010-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100086916-A1 | OLIGONUCLEOTIDE PROBES AND USES THEREOF | POLRMT, DCLRE1B, RNGTT | TYMS 252/4885CYP1A2 3840/4885CYP3A4 2916/4885 |
| US-20100240103-A1 | OLIGONUCLEOTIDES LABELED WITH A PLURALITY OF FLUOROPHORES | RNASE1, NT5E, POLI | TYMS 85/4885CYP1A2 3557/4885CYP3A4 2062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.